These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3680562)

  • 21. Effect of nilvadipine on the development of neurological deficits in stroke-prone spontaneously hypertensive rats.
    Takakura S; Furuichi Y; Yamamoto T; Ogawa T; Satoh H; Mori J
    Stroke; 1994 Mar; 25(3):677-82; discussion 682-3. PubMed ID: 8128525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of nilvadipine, a calcium antagonist, on rabbit ocular circulation and optic nerve head circulation in NTG subjects.
    Tomita K; Araie M; Tamaki Y; Nagahara M; Sugiyama T
    Invest Ophthalmol Vis Sci; 1999 May; 40(6):1144-51. PubMed ID: 10235547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated plasma nilvadipine concentration after single and chronic oral administration to patients with chronic liver disease.
    Takata Y; Yoshizumi T; Ito Y; Kikuchi M; Ueno M; Tsukashima A; Kobayashi K; Fujishima M
    Eur J Clin Pharmacol; 1992; 42(5):475-9. PubMed ID: 1606993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nilvadipine on cytokine-levels and soluble factors in collagen disease complicated with essential hypertension.
    Kagawa H; Nomura S; Ozaki Y; Nagahama M; Fukuhara S
    Clin Exp Hypertens; 1999 Oct; 21(7):1177-88. PubMed ID: 10513835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
    Tokuma Y; Fujiwara T; Noguchi H
    Xenobiotica; 1987 Nov; 17(11):1341-9. PubMed ID: 3433803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute hemodynamic effects of nilvadipine, a new calcium channel blocker, in patients with congestive heart failure.
    Sato H; Ikenouchi H; Aoyagi T; Matsui H; Mochizuki T; Momomura S; Serizawa T; Iizuka M; Sugimoto T
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):317-22. PubMed ID: 1689429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 24-hour blood pressure control after single daily doses of nivaldipine in patients with essential hypertension.
    Lossnitzer K; Huber HJ; Kuchlbauer R; Quitzdorff G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S35-42. PubMed ID: 1283187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.
    Koseki N; Araie M; Tomidokoro A; Nagahara M; Hasegawa T; Tamaki Y; Yamamoto S
    Ophthalmology; 2008 Nov; 115(11):2049-57. PubMed ID: 18672290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
    Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of lomerizine, a new Ca(2+)channel blocker, on the microcirculation in the optic nerve head in conscious rabbits: a study using a laser speckle technique.
    Shimazawa M; Sugiyama T; Azuma I; Araie M; Iwakura Y; Watari M; Sakai T; Hara H
    Exp Eye Res; 1999 Aug; 69(2):185-93. PubMed ID: 10433855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benidipine hydrochloride--a new calcium-channel blocker of the dihydropyridine type. Pharmacokinetics, pharmacodynamics, tolerance and dose finding in mild to moderate hypertension.
    Maier-Lenz H; Rode H; Lenau H; Thieme G; Wölke E; Kobayashi H; Kobayashi S; Oka T
    Arzneimittelforschung; 1988 Nov; 38(11A):1757-63. PubMed ID: 3219156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nilvadipine in hypertension with renal dysfunction.
    Berger HH; Albert FW
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S73-9. PubMed ID: 1283194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation dependent pharmacokinetics--does the dosage form matter for nifedipine?
    Toal CB
    J Cardiovasc Pharmacol; 2004 Jul; 44(1):82-6. PubMed ID: 15175561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
    Tsuda Y; Satoh K; Kitadai M; Izumi Y; Takahashi T
    Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
    Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
    Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An assessment of the pharmacokinetics and pharmacodynamics of single doses of amlodipine in elderly normotensives.
    Elliott HL; Green ST; Vincent J; Meredith PA
    Pharmacol Res; 1992; 26(1):33-9. PubMed ID: 1387475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythrocyte sodium cannot predict hypotensive effects of calcium channel blockers.
    Oshima T; Matsuura H; Ozono R; Ishida-Kainouchi M; Ishida T; Ishibashi K; Watanabe M; Okura Y; Kanbe M; Kajiyama G
    Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1227-31. PubMed ID: 8139134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, nilvadipine.
    Tsuchihashi T; Tsukashima A; Matsumura K; Abe I; Tominaga M; Nakao Y; Kobayashi K; Fujishima M
    Eur J Clin Pharmacol; 1991; 41(3):255-7. PubMed ID: 1748143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nilvadipine inhibits acute rise of aqueous flare and intraocular pressure induced by prostaglandin E2 in pigmented rabbits.
    Zhang XY; Hiraki S; Hayasaka S
    Ophthalmic Res; 1998; 30(3):135-41. PubMed ID: 9618717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.